Skip to main content

Woodline Partners LP

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1784547 San Francisco, CA

Position in ACAD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$15,056,686
+$11,824,679 QoQ
Shares Held
676,401
+346.6% QoQ
Ownership
0.395%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
17 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. ACAD ranks #60 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACAD

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,056,686 676,401
2025-09-30 $3,232,007 151,453
2025-06-30 $18,058,382 837,199
2025-03-31 $4,903,438 295,210
2024-12-31 $491,137 26,765
2023-12-31 $14,845,918 474,159
2023-06-30 $19,887,002 830,355
2023-03-31 $8,109,632 430,905
2022-09-30 $6,471,181 395,549
2022-06-30 $3,662,935 259,967
2021-12-31 $9,714,108 416,200
2021-09-30 $9,780,947 588,859
2021-06-30 $16,171,887 663,054
2021-03-31 $10,077,247 390,591
2020-12-31 $2,721,808 50,913
2020-09-30 $13,505,868 327,415
2020-06-30 $2,984,540 61,575